Bernzott Sells $10.5 Million of Hillenbrand Stock

Bernzott Capital Advisors fully liquidated its Hillenbrand (NYSE:HI) position, selling 389,330 shares in an estimated $10.53 million transaction and reducing the stake from roughly 5.0% of the fund's 13F-reportable AUM to zero. Hillenbrand, a diversified industrial with a $2.25 billion market cap, TTM revenue of $2.67 billion and TTM net income of $43.1 million, is the target of a $32-per-share buyout by an affiliate of Lone Star Funds; shares traded near $31.90 on Feb. 2, leaving limited upside unless a competing bid emerges.

Analysis

Market structure: Lone Star’s $32 cash bid crystallizes value for public HI holders and removes a free-floated ~100% of that position, benefiting private-equity lenders, advisors and arbitrage desks while compressing HI share volatility and liquidity. Public comps in industrial machinery/molding (mid-cap manufacturing names) lose a visible takeout comparator, which can temporarily dislocate relative valuations and multiples across the small-cap industrial grouping by 5–15% until new comps stabilize.

Risk assessment: Key tail risks are (1) financing strain for Lone Star (leveraged loan/levered-B/S covenant shock) or (2) regulatory/antitrust or buyer due diligence that lengthens the timeline — either can blow out the tiny arbitrage spread (>+$0.50) and create 10–30% downside if deal fails. Timelines: immediate (days) = spread and liquidity effects; short (1–6 months) = deal close/financing; long (12+ months) = asset reorganization under PE and potential strategic sales.

Trade implications: Direct risk-arb only if spread >$0.50 or implied IRR >5% annualized; otherwise redeploy proceeds into idiosyncratic small-cap industrial-tech winners (TIC, CMCO) where Bernzott retains positions. Use pair trades to neutralize cyclical beta (long TIC/CMCO, short XLI equal dollar) and options (buy puts for downside protection on any long HI arb exposure) to cap tail loss.

Contrarian angles: Consensus treats HI as a closed deal — that understates financing and timeline risk; if credit costs tick up or a competing bid emerges, spreads could widen to $1–$3 (3–9% of cap) creating an actionable arb entry. Historical parallels: mid‑cap industrial takeovers in 2019–2020 widened spreads 2–5% when leveraged loan markets re-priced; monitor loan-market spreads and HSR clearance windows as lead indicators.

Key Decisions for Investors

• If considering HI (Hillenbrand) risk-arbitrage: establish a long position only if spread to $32 offer is ≥$0.50 (price ≤$31.50). Size at ≤2% of AUM, hedge market beta by shorting S&P exposure equal to position beta, and set a hard stop/exit if spread widens to >$2 (implied deal distress) or if the deal is extended beyond 6 months.
• Establish 2–3% long positions in TIC (TIC) and CMCO (CMCO) on a 6–12 month horizon; pair each long with an equal-dollar short of XLI to neutralize industrial cyclicality. Use a 20% stop-loss and target 15–30% upside if fundamentals/flows continue to re-rate mid-cap industrial tech.
• Reduce broad industrial ETF exposure (XLI) by 3–5% and reallocate into defensive service/exposure to funeral services or recurring-revenue industrial services (allocate into TIC/CMCO or healthcare equipment names) to lower cyclicality over the next 3–12 months.
• Options tactical: if deploying risk-arb on HI, buy 3–6 month ATM puts (or put spreads) sized to cap downside to ~5–7% of position value; alternatively enter a covered-call on long TIC after purchase to harvest 3–6% quarterly yield if implied vol remains low.